Mesothelioma:
Pemetrexed in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.
Non-Small Cell Lung Cancer:
Indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer after prior chemotherapy.
